Abraham Morgentaler, MD, FACS

Benign prostatic hyperplasia is an important and under-recognized health issue for men. There is a great need for development of effective and safe alternatives to current treatment options.

We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today